|
Back to Home » February 2011 News » Equity Research on Bristol-Myers Squibb Co. and AstraZeneca plc - Pricing and Expiring Patents Threaten Revenues for Drug Manufacturers |
Equity Research on Bristol-Myers Squibb Co. and AstraZeneca plc - Pricing and Expiring Patents Threaten Revenues for Drug Manufacturers |
February 01, 2011
JOHANNESBURG, SOUTH AFRICA--(Marketwire - February 1, 2011) - www.stockcall.com/ offers investors comprehensive research on the drug manufacturers - major industry and has completed analytical research on Bristol-Myers Squibb Co. (NYSE: BMY) and AstraZeneca plc (NYSE: AZN). Register with us today at www.stockcall.com/ to have free access to these researches.
Source URL: http://www.marketwire.com/mw/release.do?id=1388269&sourceType=3
|
|
|
|
